2023. Efficacy of spesolimab for the treatment of GPP flares across prespecified patient subgroups in the Effisayil 1 study. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s121. DOI:https://doi.org/10.25251/skin.7.supp.121.